Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neyts

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Journal of Medical Virology|May 1, 1992
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency miceJ Neyts, J Balzarini, L Naesens, et al.
Antiviral Research|May 1, 1996
Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infectionsJ Neyts, A Meerbach, P McKenna, et al.
Oncology Research|January 1, 1997
The sulfonic acid polymers PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)] and related analogues are highly potent inhibitors of angiogenesisS Liekens, J Neyts, B Degrève, et al.
Indian Journal of Pharmaceutical Sciences|April 9, 2010
Studies of Antiviral Activity and Cytotoxicity of Wrightia tinctoria and Morinda citrifoliaP Selvam, N Murugesh, M Witvrouw, et al.
Advances in Virus Research|January 13, 2004
Prospects for antiviral therapyP Leyssen, N Charlier, J Paeshuyse, et al.
Journal of Virological Methods|November 1, 1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agentsJ Neyts, R Snoeck, D Schols, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1993
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient miceJ Neyts, H Sobis, R Snoeck, et al.
Virology|November 1, 1990
Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)J Neyts, R Snoeck, D Schols, et al.
Antiviral Research|July 1, 1991
Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization techniqueR Snoeck, D Schols, G Andrei, et al.
Cancer Research|July 4, 1998
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovirS Liekens, G Andrei, M Vandeputte, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Journal of Medical Virology|May 1, 1992
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency miceJ Neyts, J Balzarini, L Naesens, et al.
Antiviral Research|May 1, 1996
Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infectionsJ Neyts, A Meerbach, P McKenna, et al.
Oncology Research|January 1, 1997
The sulfonic acid polymers PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)] and related analogues are highly potent inhibitors of angiogenesisS Liekens, J Neyts, B Degrève, et al.
Indian Journal of Pharmaceutical Sciences|April 9, 2010
Studies of Antiviral Activity and Cytotoxicity of Wrightia tinctoria and Morinda citrifoliaP Selvam, N Murugesh, M Witvrouw, et al.
Advances in Virus Research|January 13, 2004
Prospects for antiviral therapyP Leyssen, N Charlier, J Paeshuyse, et al.
Journal of Virological Methods|November 1, 1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agentsJ Neyts, R Snoeck, D Schols, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1993
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient miceJ Neyts, H Sobis, R Snoeck, et al.
Virology|November 1, 1990
Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)J Neyts, R Snoeck, D Schols, et al.
Antiviral Research|July 1, 1991
Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization techniqueR Snoeck, D Schols, G Andrei, et al.
Cancer Research|July 4, 1998
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovirS Liekens, G Andrei, M Vandeputte, et al.
Pageof 12